$184.69
1.14% today
NYSE, Dec 04, 06:44 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$182.61
+3.77 2.11% 1M
+9.02 5.20% 6M
+31.75 21.05% YTD
+20.67 12.76% 1Y
+33.69 22.62% 3Y
+59.79 48.68% 5Y
+116.40 175.80% 10Y
+132.37 263.48% 20Y
NYSE, Closing price Wed, Dec 03 2025
+0.06 0.03%

New AI Insights on Quest Diagnostics Insights AI Insights on Quest Diagnostics

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$20.3b
Enterprise Value
$25.6b
Net debt
$5.2b
Cash
$432.0m
Shares outstanding
111.0m
Valuation (TTM | estimate)
P/E
21.4 | 18.4
P/S
1.9 | 1.8
EV/Sales
2.4 | 2.3
EV/FCF
18.3
P/B
2.8
Dividends
DPS
$3.20
Yield 1Y | 5Y
1.8% | 2.0%
Growth 1Y | 5Y
6.7% | 7.4%
Payout 1Y | 3Y
39.2% | 36.6%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$10.9b | $11.1b
EBITDA
$1.8b | $2.2b
EBIT
$1.6b | $1.7b
Net Income
$963.0m | $1.1b
Free Cash Flow
$1.4b
Growth (TTM | estimate)
Revenue
13.7% | 12.4%
EBITDA
21.9% | 42.7%
EBIT
21.0% | 23.4%
Net Income
14.9% | 26.9%
Free Cash Flow
36.2%
Margin (TTM | estimate)
Gross
33.5%
EBITDA
16.1% | 19.8%
EBIT
14.7%
Net
8.9% | 9.9%
Free Cash Flow
12.8%
Financial Health
Equity Ratio
42.0%
Return on Equity
12.8%
ROCE
11.4%
ROIC
-
Debt/Equity
0.8
More
EPS
$8.5
FCF per Share
$12.5
Short interest
4.4%
Employees
51k
Rev per Employee
$200.0k
Show more

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Quest Diagnostics forecast:

12x Buy
50%
12x Hold
50%

Analyst Opinions

24 Analysts have issued a Quest Diagnostics forecast:

Buy
50%
Hold
50%

Financial data from Quest Diagnostics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
10,850 10,850
14% 14%
100%
- Direct Costs 7,219 7,219
13% 13%
67%
3,631 3,631
16% 16%
33%
- Selling and Administrative Expenses 1,909 1,909
13% 13%
18%
- Research and Development Expense - -
-
-
1,750 1,750
22% 22%
16%
- Depreciation and Amortization 154 154
32% 32%
1%
EBIT (Operating Income) EBIT 1,596 1,596
21% 21%
15%
Net Profit 963 963
15% 15%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Neutral
Seeking Alpha
2 days ago
Quest Diagnostics Incorporated (DGX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Neutral
Business Wire
3 days ago
MENLO PARK, Calif.--(BUSINESS WIRE)-- #MSCare--Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson's disease, today announced a strategic collaboration with Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, to make the OctaveⓇ Multipl...
Neutral
Seeking Alpha
20 days ago
Quest Diagnostics Incorporated ( DGX ) 7th Annual Healthcare Symposium November 14, 2025 8:50 AM EST Company Participants Asia Chang Conference Call Participants Kevin Dreyer - GAMCO Investors, Inc. Carri Chan David Harding Noam Krantz - Guardant Health, Inc. Alexis Tosti Presentation Kevin Dreyer GAMCO Investors, Inc. Okay. I want to welcome everyone to our 7th Annual Healthcare Symposium join...
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO James Davis
Employees 50,500
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today